203 related articles for article (PubMed ID: 3003584)
1. Post-transcriptional regulation accounts for the trans-activation of the human T-lymphotropic virus type III.
Rosen CA; Sodroski JG; Goh WC; Dayton AI; Lippke J; Haseltine WA
Nature; 1986 Feb 13-19; 319(6054):555-9. PubMed ID: 3003584
[TBL] [Abstract][Full Text] [Related]
2. A second post-transcriptional trans-activator gene required for HTLV-III replication.
Sodroski J; Goh WC; Rosen C; Dayton A; Terwilliger E; Haseltine W
Nature; 1986 May 22-28; 321(6068):412-7. PubMed ID: 3012355
[TBL] [Abstract][Full Text] [Related]
3. Molecular biology of human T-lymphotropic retroviruses.
Wong-Staal F; Ratner L; Shaw G; Hahn B; Harper M; Franchini G; Gallo R
Cancer Res; 1985 Sep; 45(9 Suppl):4539s-4544s. PubMed ID: 2990683
[TBL] [Abstract][Full Text] [Related]
4. The p40x of human T-cell leukemia virus type I is a trans-acting activator of viral gene transcription.
Seiki M; Inoue J; Takeda T; Hikikoshi A; Sato M; Yoshida M
Jpn J Cancer Res; 1985 Dec; 76(12):1127-31. PubMed ID: 3005203
[TBL] [Abstract][Full Text] [Related]
5. The trans-activator gene of HTLV-III is essential for virus replication.
Fisher AG; Feinberg MB; Josephs SF; Harper ME; Marselle LM; Reyes G; Gonda MA; Aldovini A; Debouk C; Gallo RC
Nature; 1986 Mar 27-Apr 2; 320(6060):367-71. PubMed ID: 3007995
[TBL] [Abstract][Full Text] [Related]
6. Signaling via the CD2 receptor enhances HTLV-1 replication in T lymphocytes.
Guyot DJ; Newbound GC; Lairmore MD
Virology; 1997 Jul; 234(1):123-9. PubMed ID: 9234953
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional and post-transcriptional gene regulation of HTLV-1.
Kashanchi F; Brady JN
Oncogene; 2005 Sep; 24(39):5938-51. PubMed ID: 16155601
[TBL] [Abstract][Full Text] [Related]
8. Enhanced human T-cell lymphotropic virus type I expression following induction of the cellular stress response.
Andrews JM; Oglesbee MJ; Trevino AV; Guyot DJ; Newbound GC; Lairmore MD
Virology; 1995 Apr; 208(2):816-20. PubMed ID: 7747457
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of human T-lymphotropic leukemia virus type III associated with the acquired immunodeficiency syndrome.
Wong-Staal F; Hahn BH; Shaw GM; Arya SK; Harper M; Gonda M; Gilden R; Ratner L; Starcich B; Okamoto T
Princess Takamatsu Symp; 1984; 15():291-300. PubMed ID: 6100646
[TBL] [Abstract][Full Text] [Related]
10. Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).
Arya SK; Guo C; Josephs SF; Wong-Staal F
Science; 1985 Jul; 229(4708):69-73. PubMed ID: 2990040
[TBL] [Abstract][Full Text] [Related]
11. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
[TBL] [Abstract][Full Text] [Related]
12. Tax-independent stimulation of human T-cell leukemia virus type-I expression and differential effects on its infectivity by subtoxic and toxic doses of 3-methylcholanthrene.
Revazova T; Dombrovsky A; Lochelt M; Flugel RM; Aboud M
Cell Mol Biol Res; 1995; 41(5):377-85. PubMed ID: 8867784
[TBL] [Abstract][Full Text] [Related]
13. Expression and characterization of the trans-activator of HTLV-III/LAV virus.
Wright CM; Felber BK; Paskalis H; Pavlakis GN
Science; 1986 Nov; 234(4779):988-92. PubMed ID: 3490693
[TBL] [Abstract][Full Text] [Related]
14. Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.
Sodroski J; Patarca R; Rosen C; Wong-Staal F; Haseltine W
Science; 1985 Jul; 229(4708):74-7. PubMed ID: 2990041
[TBL] [Abstract][Full Text] [Related]
15. The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat.
Rosen CA; Sodroski JG; Haseltine WA
Cell; 1985 Jul; 41(3):813-23. PubMed ID: 2988790
[TBL] [Abstract][Full Text] [Related]
16. Nakahara memorial lecture. Human T-cell leukemia virus type I: molecular biology and its implications in adult T-cell leukemia.
Yoshida M; Kiyokawa T; Watanabe T; Hattori S; Fujisawa J; Seiki M
Princess Takamatsu Symp; 1984; 15():39-47. PubMed ID: 6100651
[TBL] [Abstract][Full Text] [Related]
17. Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.
Sodroski JG; Rosen CA; Haseltine WA
Science; 1984 Jul; 225(4660):381-5. PubMed ID: 6330891
[TBL] [Abstract][Full Text] [Related]
18. The bovine leukemia virus X region encodes a trans-activator of its long terminal repeat.
Katoh I; Yoshinaka Y; Sagata N; Ikawa Y
Jpn J Cancer Res; 1987 Feb; 78(2):93-8. PubMed ID: 3030987
[TBL] [Abstract][Full Text] [Related]
19. Genomic expressions of human T-lymphotropic virus (HTLV-I).
Hatanaka M; Sabe H; Tanaka A; Mori K; Siomi H; Nam S; Adachi Y; Itamura S; Hirayoshi K
AIDS Res; 1986 Dec; 2 Suppl 1():S79-85. PubMed ID: 3030351
[TBL] [Abstract][Full Text] [Related]
20. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
Nicholson JK; Cross GD; Callaway CS; McDougal JS
J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
